Theriva Biologics, Inc.
TOVX
$0.4996
-$0.0304-5.74%
AMEX
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -5.37% | -12.01% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.02% | -1.21% | |||
| Operating Income | -0.02% | 1.21% | |||
| Income Before Tax | 2.77% | 42.44% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 2.77% | 42.44% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 2.77% | 42.44% | |||
| EBIT | -0.02% | 1.21% | |||
| EBITDA | -0.05% | 1.09% | |||
| EPS Basic | 2.40% | 76.62% | |||
| Normalized Basic EPS | -1.33% | 59.63% | |||
| EPS Diluted | 2.40% | 76.62% | |||
| Normalized Diluted EPS | -1.33% | 59.63% | |||
| Average Basic Shares Outstanding | -0.38% | 146.20% | |||
| Average Diluted Shares Outstanding | -0.38% | 146.20% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||